Price $57.99 |
Market Cap
8.87B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
7.28
|
P/S
11.34
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-20.3K
|
FCF
-0.4
|
|
Op. Margin
-26.00%
|
Net Margin
-25.60%
|
ROE
-16.40%
|
ROI
-13.60%
|
|
ROA
-11.50%
|
EPS Growth
28.00%
|
Current Ratio
3.7
|
Debt/Equity
23.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| STRATA Skin Sciences Inc (SSKN) | $1.86 | - | - | 5.8M | Strong Buy |
| Palatin Technologies, Inc. (PTN) | $0.44 | - | - | 62.6M | Strong Buy |
| Pernix Therapeutics Holdings I (PTX) | $3.45 | - | - | 40.4M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.48 | - | - | 4M | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $17.71 | - | - | 5.89B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
